A Randomised Pilot Study of Neoadjuvant Everolimus Plus Letrozole Compared With FEC in Postmenopausal Patients With ER-positive, HER2-negative Breast Cancer
Phase of Trial: Phase II
Latest Information Update: 12 May 2017
At a glance
- Drugs Everolimus (Primary) ; Letrozole (Primary) ; Cyclophosphamide; Epirubicin; Fluorouracil
- Indications Breast cancer
- Focus Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 31 Mar 2017 Planned End Date changed from 1 Jul 2018 to 1 Jul 2019.
- 31 Mar 2017 Planned primary completion date changed from 1 Jul 2018 to 1 Jul 2019.